Compare Sana Biotechnology Inc (SANA) vs Snap Inc (SNAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Snap Inc — how do they compare? Sana Biotechnology Inc trades at $3.78 (market cap $1.13B), while Snap Inc trades at $5.5 (market cap $9.32B). The key difference: Snap Inc is far larger — about 8.2× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | SNAP | |
|---|---|---|
Market Cap | $1.13B | $9.32B |
Sector | Health | Media |
52-Week High | $5.92 | $9.09 |
52-Week Low | $2.68 | $3.93 |
Enterprise Value | $1.05B | $10.88B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Snap Inc. (SNAP) trades at $5.34, up 0.19% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with Q2 2026 revenue growth of 19% year-over-year to $1.60 billion and a narrowing net loss, beating analyst expectations. Operating cash flow strengthened to $656 million in 2025, while the stock trades below the consensus price target of $7.02 with 38% of analysts rating it a buy.
The outlook suggests potential upside from continued advertising revenue growth and cost discipline, but risks include persistent net losses, high debt levels, and competitive pressures in social media. Investor sentiment is cautiously optimistic amid earnings beats and insider selling activity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →
